BAT Launches High-Capacity Vuse Box Vape in South Korea

Nov.20.2024
BAT Launches High-Capacity Vuse Box Vape in South Korea
BAT South Korean subsidiary has launched the high-capacity product line "Vuse Box" under the "Vuse" brand. The device offers four flavors, a 6ml capacity, and up to 3,000 puffs, priced at $18. BAT stated that the new product aims to enhance user experience and expand its market share.

According to a report by N.News on November 20th, industry sources have revealed that the Korean subsidiary of British American Tobacco will be launching four models of the high-capacity disposable e-cigarette "Vuse Box" next week.

 

The new product includes four flavors: Cold Fresh, Purple Fresh, Pullet Fresh, and Green Spark, and will be available for purchase at convenience stores starting on the 24th.

 

According to reports, the "Vuse Box" product has a capacity of 6 milliliters and can be used up to 3000 times. It supports both regular and enhanced modes, with a suggested retail price of 25,000 Korean Won (18 US dollars).

 

On the 19th, the company launched the slim version of the e-cigarette "Vuse Go Slim." The boost mode feature of Vuse Go Slim is also being introduced to the "Vuse Box.

 

According to reports, sales of the "Vuse Go 800" have more than doubled within a month of its release, a result of BAT's ongoing efforts to expand the range of markets for the "Vuse" brand.

 

Industry insiders said: "Compared to regular cigarettes, this product is more affordable, and  convenient, and the large capacity design enhances the user experience."

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.